Prihlásiť sa Zaregistrujte sa zadarmo

Prevádzková marža spoločnosti RepliCel Life Sciences

Aká je hodnota metriky Prevádzková marža spoločnosti RepliCel Life Sciences?

Hodnota metriky Prevádzková marža spoločnosti RepliCel Life Sciences, Inc. je -349.72%

Aká je definícia metriky Prevádzková marža?



Prevádzková marža je pomer prevádzkových výnosov vydelený čistými predajmi a vyjadrený v percentách.

Operating margin is an indicator of profitability and is often used to compare the profitability of companies and industries of differing sizes. Companies are collections of projects and markets, individual areas can be judged on how successful they are at adding to the corporate net profit. Not all projects are of equal size, however, and one way to adjust for size is to divide the profit by sales revenue. The resulting ratio is the percentage of sales revenue that gets 'returned' to the company as net profits after all the related costs of the activity are deducted.

Prevádzková marža spoločností v sektore Health Care sektor na TSXV v porovnaní so spoločnosťou RepliCel Life Sciences

Čomu sa venuje spoločnosť RepliCel Life Sciences?

RepliCel Life Sciences Inc., a regenerative medicine company, focuses on developing autologous cell therapies that treat functional cellular deficits. Its treatments use autologous cell therapy, which isolates an individual's own cells from harvested tissues and growing more in controlled conditions in a laboratory. The company's product candidates include RCT-01, which has completed Phase I clinical trials for the treatment of chronic tendinosis; RCS-01 that is in Phase 2 clinical trials to treat aging and sun damaged skin; and RCH-01, which is in Phase 2 clinical trials for the treatment of hair loss. It is also developing RCI-02, a dermal injection device. The company has a collaboration and technology transfer agreement with YOFOTO (China) Health Industry Co. Ltd. for establishing a clinical research program to develop and commercialize RCS-01 and RCT-01; and collaboration and technology transfer agreement with Shiseido Company, Limited for establishing a clinical research program for RCH-01. It also has a collaboration research project agreement with the University of British Columbia to build a hair follicle cell data map. RepliCel Life Sciences Inc. is headquartered in Vancouver, Canada.

Firmy s metrikou prevádzková marža podobnou spoločnosti RepliCel Life Sciences